Hot Stock
Während die Wall Street über Krypto-ETFs debattiert, liefert dieses Unternehmen 1.000 % RENDITE!!
Anzeige
FIBROGEN WKN: A12EZ0 ISIN: US31572Q8087 Kürzel: 1FG Forum: Aktien Thema: Hauptdiskussion
0,4986 USD
+3,88 %+0,0186
24. Dec, 23:00:00 Uhr,
Nasdaq
Kommentare 210
Summer.76,
22.06.2021 21:57 Uhr
1
FibroGen is facing a milestone this week: Mizuho
https://seekingalpha.com/news/3708878-fibrogen-is-facing-a-milestone-this-week-mizuho
• Fibrogen (FGEN -0.5%) is awaiting a key decision on its oral small molecule inhibitor Roxadustat as the European Medicines Agency (EMA) is set to decide on its approval for the treatment of anemia in adults with chronic kidney disease.
• The decision expected this week will lead Fibrogen shares to move, Mizuho analysts led by Difei Yang note adding that the investors will consider the opinion of EMA’s Committee for Medicinal Products for Human Use ("CHMP") as a read through to an upcoming FDA Adcom meeting.
• “A positive CHMP opinion in both the dialysis-dependent and non-dialysis-dependent settings would help de-risk next month's AdCom, in our opinion,” the analysts wrote.
• In connection with the company’s New Drug Application (NDA) for roxadustat, the FDA has tentatively scheduled a meeting of its expert panel on July 15, Fibrogen announced last month.
Summer.76,
17.06.2021 13:37 Uhr
0
FibroGen and HiFiBiO Announce Transformative Partnership to Advance Next-Generation Therapies for Patients with Cancer and Autoimmune Disease
https://www.globenewswire.com/news-release/2021/06/17/2248801/33525/en/FibroGen-and-HiFiBiO-Announce-Transformative-Partnership-to-Advance-Next-Generation-Therapies-for-Patients-with-Cancer-and-Autoimmune-Disease.html
• FibroGen Exclusively Licenses HiFiBiO’s Galectin-9 Program, and Obtains an Exclusive Option to their CXCR5 and CCR8 Programs
• Transformative Transaction for FibroGen’s Early-stage Pipeline
• HiFiBiO to Receive $25 Million Upfront, and Up to a Total of $1.1B in Additional Milestone Payments Across All Three Programs, Plus Royalties
...
Adler.,
16.06.2021 17:01 Uhr
0
👍
Summer.76,
16.06.2021 15:41 Uhr
0
Pancreatic Cancer Action Network Partners With FibroGen To Bring New Experimental Treatment Arm To Adaptive Clinical Trial, Precision Promise(SM)
https://www.prnewswire.com/news-releases/pancreatic-cancer-action-network-partners-with-fibrogen-to-bring-new-experimental-treatment-arm-to-adaptive-clinical-trial-precision-promisesm-301313531.html
Addition Marks First Experimental Therapy Offered as Either First- or Second-Line Option for Pancreatic Cancer Patients Enrolled in Novel Trial Platform
R
Rosneft,
26.05.2021 13:29 Uhr
0
Wieso geht's weiter nach unten, Leute, wo ist der Boden?
Summer.76,
10.05.2021 22:25 Uhr
1
FibroGen Reports First Quarter 2021 Financial Results
https://www.globenewswire.com/news-release/2021/05/10/2226627/0/en/FibroGen-Reports-First-Quarter-2021-Financial-Results.html
• Roxadustat net product revenue in China of $15.4 million, on a US GAAP basis
• Total roxadustat net sales in China of $43.5 million1 by FibroGen and the distribution entity jointly owned by FibroGen and AstraZeneca, compared to $29.2 million last quarter
• FDA to hold Advisory Committee Meeting on Roxadustat NDA - tentative date July 15, 2021
...
Summer.76,
15.04.2021 16:15 Uhr
1
FibroGen Receives Rare Pediatric Disease Designation from the U.S. FDA for Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy
https://www.globenewswire.com/news-release/2021/04/15/2210640/33525/en/FibroGen-Receives-Rare-Pediatric-Disease-Designation-from-the-U-S-FDA-for-Pamrevlumab-for-the-Treatment-of-Duchenne-Muscular-Dystrophy.html
Summer.76,
12.04.2021 16:20 Uhr
1
FibroGen Receives Fast Track Designation from the U.S. FDA for Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy
https://www.globenewswire.com/news-release/2021/04/12/2208102/33525/en/FibroGen-Receives-Fast-Track-Designation-from-the-U-S-FDA-for-Pamrevlumab-for-the-Treatment-of-Duchenne-Muscular-Dystrophy.html
HellCyborg,
08.04.2021 13:01 Uhr
0
Anschnallen oder guter Einstiegskurs?
Summer.76,
07.04.2021 20:37 Uhr
0
https://de.investing.com/news/stock-market-news/fibrogenaktie-crasht-unstimmigkeiten-bei-sicherheitsdaten-2122890
Fibrogen-Aktie crasht: Unstimmigkeiten bei Sicherheitsdaten
Schwan,
07.04.2021 16:11 Uhr
0
Was los hier
w
wiejulius,
07.04.2021 14:49 Uhr
0
🥺🥺🥺
Adler.,
01.04.2021 0:27 Uhr
0
Yeeaah 👍👍👍
Summer.76,
02.03.2021 16:26 Uhr
0
*** durch finanz.trends (ohne den Punkt) ersetzen
Summer.76,
02.03.2021 16:26 Uhr
0
https://www.finanztrends.de/biotech-aktien-der-taegliche-biotech-puls-2/
z
zsclions,
02.03.2021 16:10 Uhr
0
gibts auch news auf deutsch?warum absturz
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | für alle, die es ehrlich meinen beim Traden. | ||
2 | Lilium Aktie | +268,39 % | |
3 | BAYER Hauptdiskussion | -0,63 % | |
4 | Nio für normale Kommunikation | +2,90 % | |
5 | ATOS Hauptdiskussion | -15,15 % | |
6 | RHEINMETALL Hauptdiskussion | +2,46 % | |
7 | Security der nächsten Generation | +22,35 % | |
8 | Cherry Hauptdiskussion | +15,17 % | |
9 | BRITISH AMERICAN TOBACCO Hauptdiskussion | +6,68 % | |
10 | News - InnoCan Pharma Aktie | +10,53 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | Lilium Aktie | +268,39 % | |
2 | BAYER Hauptdiskussion | -0,63 % | |
3 | Nio für normale Kommunikation | +2,33 % | |
4 | ATOS Hauptdiskussion | -15,15 % | |
5 | RHEINMETALL Hauptdiskussion | +2,46 % | |
6 | Security der nächsten Generation | +22,35 % | |
7 | Cherry Hauptdiskussion | +15,17 % | |
8 | BRITISH AMERICAN TOBACCO Hauptdiskussion | +6,68 % | |
9 | News - InnoCan Pharma Aktie | +10,53 % | |
10 | NEL ASA Hauptdiskussion | -1,10 % | Alle Diskussionen |